{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:07:44Z","timestamp":1792804064763,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009395","name":"CancerCare Manitoba Foundation","doi-asserted-by":"publisher","award":["763045126"],"award-info":[{"award-number":["763045126"]}],"id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00198-022-06542-4","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T02:03:31Z","timestamp":1661738611000},"page":"2629-2635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fractures and long-term mortality in cancer patients: a population-based cohort study"],"prefix":"10.1007","volume":"33","author":[{"given":"Carrie","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Al-Azazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Czaykowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"6542_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","volume":"377","author":"MP Coleman","year":"2011","unstructured":"Coleman MP, Forman D, Bryant H et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. The Lancet 377:127\u2013138","journal-title":"The Lancet"},{"key":"6542_CR2","unstructured":"Singh H, Al-Azazi S, Yan L, Lix L, Czaykowski P, Edwards B, Leslie WD 2017 Fracture risk among 122,205 cancer patients: a population-based cohort study from Manitoba, Canada. J Bone Miner Res 32 (Suppl 1). Available at https:\/\/www.asbmr.org\/meetings\/2017-abstracts. Accessed May 18, 2022"},{"key":"6542_CR3","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1200\/JCO.19.01696","volume":"37","author":"CL Shapiro","year":"2019","unstructured":"Shapiro CL, Van Poznak C, Lacchetti C et al (2019) Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO Clinical Practice Guideline. J Clin Oncol 37:2916\u20132946","journal-title":"J Clin Oncol"},{"key":"6542_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.11005\/jbm.2020.27.1.27","volume":"27","author":"S Lee","year":"2020","unstructured":"Lee S, Yoo J-I, Lee Y-K et al (2020) Risk of osteoporotic fracture in patients with breast cancer: meta-analysis. J Bone Metab 27:27\u201334","journal-title":"J Bone Metab"},{"key":"6542_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.652979","volume":"12","author":"CC Wu","year":"2021","unstructured":"Wu CC, Chen PY, Wang SW et al (2021) Risk of fracture during androgen deprivation therapy among patients with prostate cancer: a systematic review and meta-analysis of cohort studies. Front Pharmacol 12:652979","journal-title":"Front Pharmacol"},{"key":"6542_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074492","volume":"8","author":"M Van Hemelrijck","year":"2013","unstructured":"Van Hemelrijck M, Garmo H, Micha\u00eblsson K et al (2013) Mortality following hip fracture in men with prostate cancer. PLoS ONE 8:e74492","journal-title":"PLoS ONE"},{"key":"6542_CR7","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1200\/JCO.2012.42.2097","volume":"30","author":"MB Lustberg","year":"2012","unstructured":"Lustberg MB, Reinbolt RE, Shapiro CL (2012) Bone health in adult cancer survivorship. J Clin Oncol 30:3665\u20133674","journal-title":"J Clin Oncol"},{"key":"6542_CR8","first-page":"269","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC) (2011) Cancer survivors\u2013United States, 2007. MMWR Morb Mortal Wkly Rep 60:269\u2013272","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6542_CR9","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1093\/annonc\/mdr017","volume":"22","author":"P Hadji","year":"2011","unstructured":"Hadji P, Aapro MS, Body JJ et al (2011) Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment. Ann Oncol 22:2546\u20132555","journal-title":"Ann Oncol"},{"key":"6542_CR10","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.3747\/co.v18i4.746","volume":"18","author":"CE Lee","year":"2011","unstructured":"Lee CE, Leslie WD, Czaykowski P et al (2011) A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy. Curr Oncol 18:e163\u2013e172","journal-title":"Curr Oncol"},{"key":"6542_CR11","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","volume":"31","author":"R Coleman","year":"2020","unstructured":"Coleman R, Hadji P, Body J-J et al (2020) Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol 31:1650\u20131663","journal-title":"Ann Oncol"},{"key":"6542_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","volume":"163","author":"HW Daniell","year":"2000","unstructured":"Daniell HW, Dunn SR, Ferguson DW et al (2000) Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol 163:181\u2013186","journal-title":"J Urol"},{"key":"6542_CR13","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00198-016-3899-6","volume":"28","author":"AR Hong","year":"2017","unstructured":"Hong AR, Kim JH, Lee KH et al (2017) Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer. Osteoporos Int 28:1413\u20131422","journal-title":"Osteoporos Int"},{"key":"6542_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11914-013-0154-3","volume":"11","author":"MT Drake","year":"2013","unstructured":"Drake MT (2013) Osteoporosis and cancer. Curr Osteoporos Rep 11:163\u2013170","journal-title":"Curr Osteoporos Rep"},{"key":"6542_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2105\/AJPH.87.3.398","volume":"87","author":"FD Wolinsky","year":"1997","unstructured":"Wolinsky FD, Fitzgerald JF, Stump TE (1997) The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health 87:398\u2013403","journal-title":"Am J Public Health"},{"key":"6542_CR16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","volume":"353","author":"JR Center","year":"1999","unstructured":"Center JR, Center JR, Nguyen TV et al (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. The Lancet 353:878\u2013882","journal-title":"The Lancet"},{"key":"6542_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a116756","volume":"137","author":"C Cooper","year":"1993","unstructured":"Cooper C, Atkinson EJ, Jacobsen SJ et al (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001\u20131005","journal-title":"Am J Epidemiol"},{"key":"6542_CR18","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s00198-010-1480-2","volume":"22","author":"S Morin","year":"2011","unstructured":"Morin S, Lix LM, Azimaee M et al (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22:2439\u20132448","journal-title":"Osteoporos Int"},{"key":"6542_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1503\/cmaj.081720","volume":"181","author":"G Ioannidis","year":"2009","unstructured":"Ioannidis G, Papaioannou A, Hopman WM et al (2009) Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ 181:265\u2013271","journal-title":"CMAJ"},{"key":"6542_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2014.125","volume":"10","author":"SE Sattui","year":"2014","unstructured":"Sattui SE, Saag KG (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10:592\u2013602","journal-title":"Nat Rev Endocrinol"},{"key":"6542_CR21","first-page":"24","volume":"26","author":"TC Tucker","year":"1999","unstructured":"Tucker TC, Howe HL, Weir HK (1999) Certification for population-based cancer registries. J Reg Mgmt 26:24\u201327","journal-title":"J Reg Mgmt"},{"key":"6542_CR22","unstructured":"Hotes Ellison J, Wu XC, McLaughlin C, et al (2006) Cancer in North America: 1999--2003. Incidence North American Asociation of Central Cancer Registeries Inc"},{"key":"6542_CR23","unstructured":"World Health Organization. (2013). International classification of diseases for oncology (ICD-O), 3rd ed., 1st revision. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/96612"},{"key":"6542_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/1471-2458-12-301","volume":"12","author":"LM Lix","year":"2012","unstructured":"Lix LM, Azimaee M, Osman BA et al (2012) Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 12:301","journal-title":"BMC Public Health"},{"key":"6542_CR25","unstructured":"Epp R, Alhrbi M, Ward L, Leslie W (2018) Radiological validation of fracture definitions from administrative data: the Manitoba bone mineral density database. In: JOURNAL OF BONE AND MINERAL RESEARCH. WILEY 111 RIVER ST, HOBOKEN 07030\u20135774, NJ USA, pp 275\u2013275"},{"key":"6542_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11657-013-0143-2","volume":"8","author":"S O\u2019Donnell","year":"2013","unstructured":"O\u2019Donnell S, Canadian Chronic Disease Surveillance System (CCDSS) Osteoporosis Working Group (2013) Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study. Arch Osteoporos 8:143","journal-title":"Arch Osteoporos"},{"key":"6542_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"6542_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/1472-6963-13-340","volume":"13","author":"LM Lix","year":"2013","unstructured":"Lix LM, Quail J, Fadahunsi O, Teare GF (2013) Predictive performance of comorbidity measures in administrative databases for diabetes cohorts. BMC Health Serv Res 13:340","journal-title":"BMC Health Serv Res"},{"key":"6542_CR29","unstructured":"Lix L, Smith M, Pitz M, Ahmed R, Quon H, Griffith J, Turner D, Hong S, Prior H, Banerjee A, Koseva I, Kulbaba C. Cancer data linkage in Manitoba: expanding the infrastructure for research. Winnipeg, MB. Manitoba Centre for Health Policy, January 2016"},{"key":"6542_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513\u2013521","journal-title":"JAMA"},{"key":"6542_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","volume":"152","author":"P Haentjens","year":"2010","unstructured":"Haentjens P, Magaziner J, Col\u00f3n-Emeric CS et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380\u2013390","journal-title":"Ann Intern Med"},{"key":"6542_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2288-10-20","volume":"10","author":"CA Bellera","year":"2010","unstructured":"Bellera CA, MacGrogan G, Debled M et al (2010) Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer. BMC Med Res Methodol 10:20","journal-title":"BMC Med Res Methodol"},{"key":"6542_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00520-016-3431-8","volume":"25","author":"NK Behnke","year":"2017","unstructured":"Behnke NK, Baker DK, Xu S et al (2017) Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer. Support Care Cancer 25:513\u2013521","journal-title":"Support Care Cancer"},{"key":"6542_CR34","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00198-007-0429-6","volume":"18","author":"ANA Tosteson","year":"2007","unstructured":"Tosteson ANA, Gottlieb DJ, Radley DC et al (2007) Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int 18:1463\u20131472","journal-title":"Osteoporos Int"},{"key":"6542_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Lippi G (2019) Current cancer epidemiology. J Epidemiol Glob Health 9:217\u2013222","journal-title":"J Epidemiol Glob Health"},{"key":"6542_CR36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00198-020-05325-z","volume":"31","author":"SR Cummings","year":"2020","unstructured":"Cummings SR, Eastell R (2020) Stop (mis)classifying fractures as high- or low-trauma or as fragility fractures. Osteoporos Int 31:1023\u20131024","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06542-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06542-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06542-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T04:09:32Z","timestamp":1668139772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06542-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6542"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06542-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"10 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Obtained from the University of Manitoba Health Research Ethics Board, data access approved by Manitoba Health, Health Information and Privacy Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Waiver of consent approved (administrative database study).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Carrie Ye, William Leslie, Saeed Al-Azazi, Lin Yan, Lisa Lix, and Piotr Czaykowski do not have any conflicts of interest to declare. Harminder Singh has been on the advisory boards of Takeda Canada, Amgen Canada, and Guardant Health, Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}